Cyclophosphamide trials for Prostate cancer

All Cyclophosphamide trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Prostate cancer

• Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
  NCT06193486 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
  NCT07523529 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06236139 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
  NCT07641049 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Cyclophosphamide for Prostate cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.